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The RNA-binding protein RC3H1 (also known as ROQUIN) promotes TNFamRNA decay via a
30UTR constitutive decay element (CDE). Here we applied PAR-CLIP to human RC3H1 to
identify B3,800 mRNA targets with 416,000 binding sites. A large number of sites are
distinct from the consensus CDE and revealed a structure-sequence motif with U-rich
sequences embedded in hairpins. RC3H1 binds preferentially short-lived and DNA damage-
induced mRNAs, indicating a role of this RNA-binding protein in the post-transcriptional
regulation of the DNA damage response. Intriguingly, RC3H1 affects expression of the NF-kB
pathway regulators such as IkBa and A20. RC3H1 uses ROQ and Zn-finger domains to
contact a binding site in the A20 30UTR, demonstrating a not yet recognized mode of RC3H1
binding. Knockdown of RC3H1 resulted in increased A20 protein expression, thereby
interfering with IkB kinase and NF-kB activities, demonstrating that RC3H1 can modulate the
activity of the IKK/NF-kB pathway.
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P
ost-transcriptional regulation of gene expression by RNA-
binding proteins (RBPs) controls a variety of cellular
processes. Especially, the modulation of messenger RNA
(mRNA) stability is of critical importance for the dynamic
regulation of genes such as transcription factors and cytokines
that need to be switched on and off rapidly1,2.
Roquin is an RBP with a central role in repressing auto-
immunity3. Originally, a missense mutation in the Rc3h1 gene
encoding the Roquin-1 protein was identified as the cause of
systemic lupus erythematosus-like autoimmunity phenotype in
sanroque mice3. Roquin-1 is localized in cytoplasmic granules4,5
and binds to the 30 untranslated region (30UTR) of inducible
costimulator (ICOS) mRNA to post-transcriptionally repress its
expression6,7. Furthermore, Roquin-1, as well as its paralogue
Roquin-2, interacts with 30UTR of TNFRSF4 and tumour-necrosis
factor-a (TNFa), and modulates immune responses5,8. Recent
studies showed that Roquin proteins interact through their ROQ
domains with a constitutive decay element (CDE) in the 30UTR of
TNFa mRNA and promotes the decay of this transcript by
recruiting the CCR4-CAF1-NOT deadenylase complex9. The CDE
of TNFa folds into a characteristic stem–loop structure containing
a specific trinucleotide loop, which is highly similar to the Roquin-
1 RNA recognition element in the ICOS 30UTR (ref. 9). Latest
structural analyses showed the ROQ domain in complex with a
prototypical CDE RNA stem–loop revealing recognition of the
RNA stem and its trinucleotide loop10,11. Leppek et al.9 further
identified additional Rc3h1 target transcripts by RNA-
immunoprecipitation sequencing (RIP-seq) analysis, including
regulators of the nuclear factor-kB (NF-kB) pathway. However, a
recognizable CDE was absent in the majority of Rc3h1-bound
mRNAs, suggesting other modes of RNA recognition9. In line with
these findings, Schlundt et al.10 showed by mutational and
structural analyses of RNA ligands that relaxed CDE consensus
sequences can mediate Roquin-dependent regulation. Similarly,
Tan et al.11 and Schuetz et al.12 reported that the ROQ domain of
Rc3h1 recognizes the CDE and can also bind to duplex RNA. In
addition to the ROQ domain, RC3H1 possesses an N-terminal
RING finger with a potential E3 ubiquitin–ligase function13, as well
as a CCCH-type zinc (Zn) finger that is involved in RNA
recognition7. CCCH-type Zn-finger RBPs typically contact AU-
rich elements14,15. AU-rich elements are conserved cis-regulatory
elements, originally discovered in the 30UTRs of short-lived
mRNAs, encoding inflammatory mediators16–18.
To obtain a better understanding of the molecular mechanisms
of human RC3H1 RNA recognition and disentangle its cellular
function, we applied PAR-CLIP (photoactivatable ribonucleoside-
enhanced crosslinking and immunoprecipitation)19 to identify
RC3H1 RNA-binding sites and target transcripts in HEK293 cells.
RC3H1 contacts mRNAs through structure-sequence elements
located in 30UTRs. The binding sites are composed of hairpins
with variable loop length often with embedded U-rich sequences,
including CDE consensus sequences. RC3H1-bound mRNA
targets are short-lived, and RC3H1 depletion results in
decreased mRNA decay rates and increased protein synthesis of
its target mRNAs. RC3H1 target transcripts are enriched for
mRNAs that are induced upon DNA damage, among them are
the mRNA of A20 (also known as TNFAIP3). A20 codes for
an ubiquitin-editing enzyme, which inhibits activation of
NF-kB20,21. In vitro and in vivo experiments revealed that
RC3H1 interacts with a non-CDE-type stem–loop structure
preceded by an AU-rich sequence in the A20 30UTR involving
ROQ and CCCH-type Zn-finger domains, indicating a yet
unrecognized RC3H1-binding mode and specificity. Depletion
of RC3H1 leads to increased A20 protein expression, which is
accompanied by decreased IkB kinase (IKK) activation and
NF-kB DNA-binding activity upon TNFa signalling.
Results
Human RC3H1 binds to thousands of mRNAs. To identify
RC3H1-binding sites at high resolution, we applied PAR-CLIP in
combination with next-generation sequencing19. In PAR-CLIP
experiments, nascent RNA is metabolically labelled with the non-
perturbing photoreactive ribonucleosides 4-thiouridine (4SU) or
6-thioguanosine (6SG). Crosslinking of protein to 4SU- or 6SG-
labelled RNA leads to specific T to C or G to A transitions,
respectively, that occur at high frequency in complementary DNA
(cDNA) sequence reads and mark the protein crosslinking sites
on the target RNA19. HEK293 cells stably expressing inducible
FLAG/HA-tagged RC3H1 (Supplementary Fig. 1a) were
crosslinked after labelling of RNA with either 4SU or 6SG.
Immunopurified, ribonuclease-treated and radiolabelled RC3H1–
RNA complexes were separated by SDS–polyacrylamide
gel electrophoresis (PAGE) (Fig. 1a). Protein-protected RNA
fragments were recovered and converted into a cDNA library
amenable to Illumina sequencing.
In total, we performed three independent PAR-CLIP
experiments (two biological replicates with 4SU, 4SU-1 and
4SU-2, and one replicate with 6SG; see Supplementary Table 1).
Sequence reads were mapped to the human genome and
overlapping reads were used to build RC3H1-binding clusters22.
In PAR-CLIP experiments using 4SU, diagnostic T to C
transitions detected in mapped reads were most highly
abundant (Fig. 1b and Supplementary Fig. 1b). Similarly, but
less pronounced, the diagnostic G to A changes were the most
abundant type of mutation for the 6SG PAR-CLIP experiment
(Supplementary Fig. 1c). A length histogram of RC3H1 PAR-
CLIP clusters shows a median cluster size ofB25–30 nucleotides
(Supplementary Fig. 1d).
We identified B2,000–4,000 RC3H1 mRNA target transcripts
in each of the 4SU PAR-CLIP experiments (Fig. 1c). Ninety-three
per cent of the 481 6SG PAR-CLIP mRNA targets
were reproduced in 4SU libraries (Fig. 1c). We combined the
‘reads’ from all PAR-CLIP experiments to derive a set of
consensus binding sites supported by reads from at least two
out of three experiments (see Methods section). Based on
this analysis, we identified 16,234 RC3H1-binding sites on
3,821 protein-coding transcripts as consensus data set
(Supplementary Data 1). The binding sites and PAR-CLIP
sequence alignments are publicly available at http://bimsbsta-
tic.mdc-berlin.de/landthaler/RC3H1. The position with the
highest number of PAR-CLIP-derived diagnostic nucleotide
transitions for each binding sites was referred to as the preferred
crosslinking site.
To gain an insight into the transcripts regulated by RC3H1,
genes encoding RC3H1-bound mRNAs were subjected to Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway and Gene
Ontology (GO) term enrichment analysis23,24. Interestingly, cell
cycle and p53 signalling pathway were overrepresented in the
KEGG pathway enrichment analysis (Supplementary Fig. 1e),
suggesting that RC3H1 could play a role in the response to
DNA damage. Furthermore, GO term enrichment analysis
showed that RC3H1-bound transcripts are highly enriched
for regulators of gene expression such as transcription factors,
RBPs and ubiquitin ligases (Supplementary Fig. 1f). In
addition, when comparing the human RC3H1 targets with
mouse Roquin-bound transcripts9, we identified 36 out of 55
Roquin-interacting mRNAs by PAR-CLIP in HEK293 cells
(Supplementary Fig. 1g).
RC3H1-binding sites are mostly located in 30UTR of mRNAs.
Next, we examined the distribution of RC3H1-binding sites along
mRNA transcripts. The majority of binding sites (81%) were
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8367
2 NATURE COMMUNICATIONS | 6:7367 |DOI: 10.1038/ncomms8367 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
found to be located in 30UTRs (Fig. 1d), consistent with previous
observations that RC3H1 binds to ICOS and TNFa mRNAs
through 30UTR interactions4,6,7. RC3H1 binding to ICOS and
TNFa mRNAs in HEK293 cells was not observed likely due to
undetectable ICOS and TNFa mRNA expression. A preference
for RC3H1 binding along 30UTRs of target transcripts was not
apparent, since binding clusters were almost equally distributed
over this transcript region (Supplementary Fig. 1h). Since a
previous study suggested a functional link between RC3H1
binding and microRNA (miRNA) activity6, we examined the local
interactions between RC3H1 and miRNA by computing the
density of conserved miRNA target sites around RC3H1 preferred
crosslinking sites (Supplementary Fig. 1i). The observed profile
indicated an overrepresentation of miRNA seed complements in
the vicinity of RC3H1-binding sites, but did not directly overlap
with these sites.
U-rich hairpins dominate as recognition features. To investi-
gate RNA features recognized by RC3H1, we searched for
sequence and secondary structure elements in RC3H1-binding
sites. First, we examined 7mer occurrences in 41 nucleotide
windows centred on preferred crosslinking sites in
RC3H1-binding sites. Notably, U-rich sequences were frequently
found in RC3H1-binding sites derived from both 4SU and 6SG
experiments (Fig. 2a and Supplementary Fig. 2a), suggesting
that the frequent observation of U-richness is not owing to a
bias introduced by using 4SU. These U-rich 7mers were
overrepresented in RC3H1-binding sites when compared with
control 7mers (Fig. 2b). In contrast, U-rich elements were not
enriched in IGF2BP1-binding sites19, whereas 7mer containing
the CAU consensus sequence are overrepresented (Fig. 2b).
U-rich sequences with interspersed adenosines were more
enriched in RC3H1 consensus binding sites in 30UTR sequences
when compared with U-rich 7mer sequences containing
guanosines (Supplementary Fig. 2b and Supplementary Data 2).
Similar results were also obtained from 5mer analysis
(Supplementary Fig. 2c). In addition, U-rich sequences were
found in close proximity of preferred crosslink sites, suggesting
the direct interaction of RC3H1 with these sequences (Fig. 2c). In
addition, we examined the occurrence of the previously identified
CDE motif9, and found that the core CDE consensus sequence
(UCYRYGA) was present in RC3H1-binding sites, but the
frequency was less prominent than that of several U-rich
sequences (Fig. 2c).
To examine potential secondary structure features in RC3H1-
binding sites, we computationally folded 41-nucleotide
sequence stretches centred around the preferred crosslinking
sites and averaged the resulting base pairing probabilities.
Randomly selected RNA regions of the same length within
30UTRs of RC3H1 mRNA target transcripts served as a
background control. In 30UTR RC3H1 consensus binding sites,
the base pairing probability was reduced in the vicinity of the
crosslink sites and increased in the flanking region compared with
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Figure 1 | PAR-CLIP identifies thousands of human mRNAs directly bound by RC3H1. (a) Phosphorimage of SDS–PAGE of radiolabelled FLAG/HA-
RC3H1–RNA complexes from 365nm ultraviolet light crosslinked non-labelled, 6SG- or 4SU-labelled cells. Crosslinked protein–RNA complexes were
observed upon metabolic labelling with 4SU or 6SG. The lower panel shows an anti-HA western blot, confirming correct size and equal loading of the IPed
protein. The box indicates the region that was cut out for PAR-CLIP library preparation. (b) Specific T to C mismatches in aligned reads demonstrate
efficient mRNA-RBP crosslinking. The frequency of nucleotide mismatches in 4SU-2 PAR-CLIP reads aligned to mature mRNAs is shown. Sense mapping is
shown in blue and antisense mapping in red. (c) A Venn diagram showing the overlap of target mRNA transcripts between 4SU and 6SG PAR-CLIP
experiments. (d) Distribution of binding sites along mRNA transcripts based on consensus RC3H1 PAR-CLIP-binding sites. The majority of binding sites are
located in 30UTRs. CDS, coding sequences.
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background, suggesting that RC3H1-binding sites tend to form
stem–loop structures (Supplementary Fig. 2d,e). A more detailed
examination of the types of hairpin structures enriched in RC3H1
binding revealed an overrepresentation of stems capped by
trinucleotide loops as demonstrated for the CDE motif 9–12, but
also hairpins with loops containing 4 and 5 nucleotides (Fig. 2d).
From this analysis, we concluded that there might be several
binding motifs that are likely to be structured. To test this
hypothesis, we applied a variant of an approach that was
previously used to detect structured RNA motifs25. Here we
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Figure 2 | Identification of U-rich sequences and stem–loop secondary structure as recognition elements of RC3H1. (a) Log10 frequencies of 7mers
occurring in the 41-nucleotide (nt) window around the RC3H1 preferred crosslink sites are shown for 4SU-2 PAR-CLIP and 6SG PAR-CLIP libraries. U-rich
sequences are frequently occurring in both 4SU and 6SG libraries. (b) Enrichment of indicated 7mers in the 41-nt window around the RC3H1 (left) or
IGF2BP1 (right) preferred crosslink sites compared with all 30UTR sequences. U-rich sequences with A contents are specifically enriched in RC3H1 30UTR-
binding sites, whereas 7mers containing known IGF2BP1 motif (CAU) are enriched in IGF2BP1 30UTR-binding sites to the similar degree. (c) A heat map
showing the coverage of 7mers, indicated on the left, around the preferred crosslinks in 30UTR RC3H1 consensus binding sites. U-rich elements with A
contents and CDE are indicated. U-rich sequences are found in the close vicinity of crosslink sites, which is indicative of direct association of RC3H1 with
U-rich sequences. (d) Enrichment of indicated stem–loop structures in the 41-nt window around the RC3H1 (left) or IGF2BP1 (right) preferred crosslink
sites compared with 41 nt sequences randomly selected from the 30UTRs of target transcripts as a background model. Various stem–loop structures
(n-m-n indicates a hairpin structure of n-mer stem and m-mer loop) are enriched in RC3H1 30UTR-binding sites but not in 30UTR IGF2BP1-binding sites.
(e) The seed alignment and consensus structure of motifs 1 and 2 are shown. ARE, AU-rich elements.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8367
4 NATURE COMMUNICATIONS | 6:7367 |DOI: 10.1038/ncomms8367 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
performed an initial clustering of the set of RNAs, followed by the
detection of a specific structure. We started with the top 100
RC3H1 PAR-CLIP-binding sites, and detected initial clusters by
LocARNA26,27 and RNAclust27. For each subcluster, we used
CMfinder (version 0.2; ref. 28) to search for a subset of sequences
that has a specific sequence-structure motif. CMfinder generates
both a sequence-structure alignment (referred to as seed
alignment) and a covariance model, which we used to search
for further sequences in the top 1,000 binding sites for remote
members of this motif using cmsearch29. The seed alignment of
motif 1 (present in 177 out of 1,000 binding sites) and motif 2
(present in 268 out of 1,000 binding sites), representing the most
frequently occurring sequence-structure elements, is shown in
Fig. 2e. Interestingly, in motif 2, the preferred crosslinked
nucleotides are positioned upstream of the predicted hairpin
structure, whereas in motif 1 the preferred crosslinked
nucleotides are located in the U-rich loop. In summary, our
computational analyses did not reveal a defined motif. However,
hairpin structures frequently containing U-rich sequences and,
albeit, less frequently, the CDE consensus sequence were detected
as possible recognition elements of RC3H1.
RC3H1 interacts with CCR4-CAF1-NOT deadenylase complex.
To further investigate the molecular function of RC3H1, we set
out to identify proteins that interact with RC3H1. Previous stu-
dies showed that RC3H1 destabilizes mRNA albeit by different
molecular mechanisms. Glasmacher et al.7 reported that RC3H1
interacts with mRNA decapping proteins, whereas Leppek et al.9
more recently showed that roquin protein associates with
CCR4-CAF1-NOT deadenylase complex.
To identify proteins that directly interact with RC3H1 in an
RNA-independent manner, cellular extracts of control and
FLAG/HA-tagged RC3H1-expressing cells were treated with
RNaseT1/I, and the immunoprecipitates were analysed and
compared by SILAC (stable isotope labelling by amino acids
(aa) in cell culture)-based quantitative mass spectrometry30. As a
biological replicate, we performed a label-swap experiment with
reversed light/heavy isotope labelling (Fig. 3a). As expected,
RC3H1 was efficiently immunoprecipitated as indicated by the
log2 heavy-to-light normalized ratio of 2.80 in the forward
experiment and -5.13 in the reverse experiment (Supplementary
Fig. 3a). In two biological replicates, we identified numerous
peptides originating from components of the CCR4-CAF1-NOT
−1.0 −0.5 0.0 0.5 1.0
0.0
0.2
0.4
0.6
0.8
1.0
Changes in protein synthesis (pSILAC)
Log2-fold change (siRNA/mock)
CD
F
RC3H1 targets 
Non-targets 
IN IP IN IP IN IP
P = 0.0031
−0.4 −0.2 0.0 0.2 0.4
Log2-fold change (siRNA/mock)
0.0
0.2
0.4
0.6
0.8
1.0
CD
F
Changes in mRNA decay rate
RC3H1 targets
Non-targets
P < 2.2e–16
Log2 (number of peptides)
1 2 3 4 50 6
1
2
3
4
5
0
6
Lo
g2
 (n
um
be
r o
f p
ep
tid
es
) RC3H1
CNOT1
CNOT2
CNOT3
CNOT8
CNOT7
Anti-HA
Anti-myc
QKICNOT8CNOT1
RC3H1RC3H1RC3H1
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treated before immunoprecipitation (IP) to disrupt the indirect interactions mediated by nascent RNA. Peptides derived from the CCR4-CAF1-CNOT
deadenylase complex were detected. (b) RC3H1 interactions were confirmed by co-transfection of myc-RC3H1 expression construct with HA-CNOT1,
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deadenylase complex including CNOT1, CNOT2, CNOT3,
CNOT7 and CNOT8, but not from the decapping complex
(Fig. 3a, Supplementary Fig. 3a and Supplementary Table 2).
CNOT1 is the scaffold subunit and CNOT8 is a catalytic
deadenylase subunit31. Interestingly, for proteins in the
CCR4-CAF1-NOT deadenylase complex, we obtained SILAC
ratios of B1 suggesting that RC3H1 interacts only transiently
with these proteins (Supplementary Fig. 3a). Specific interactions
of RC3H1 with CNOT1 and CNOT8, but not with the RBP QKI,
were confirmed by co-immunoprecipitation experiments in
agreement with previous findings9 (Fig. 3b), indicating that
RC3H1 generally acts as mediator of mRNA deadenylation.
RC3H1 destabilizes target mRNAs. To assess whether RC3H1
interacts with short-lived mRNA transcripts, we performed tran-
scriptome-wide mRNA half-life measurements (Supplementary
Data 3) as described by Do¨lken et al.32, and compared half-lives of
RC3H1-bound and unbound mRNA transcripts. Consistent with
the interaction of RC3H1 with the deadenylase complex and a
possible role in mRNA decay, RC3H1-targeted mRNAs were
found to have shorter half-lives than expressed non-target
transcripts (Supplementary Fig. 3b,c). On the other hand,
IGF2BP1-bound transcripts do not show this tendency
(Supplementary Fig. 3d,e). Furthermore, we found that mRNA
half-lives of RC3H1-bound transcripts inversely correlated with an
expression normalized PAR-CLIP score (Supplementary Fig. 3f),
suggesting that the extent of RC3H1–mRNA binding determined
the mRNA half-lives of bound mRNAs (Supplementary Data 4).
To examine the impact of RC3H1 on the decay rate of its
mRNA targets, we sequenced mRNA of untreated and RC3H1-
and RC3H2-depleted cells (Supplementary Fig. 3g) after inhibi-
tion of transcription using actinomycin D from two biological
replicates. Figure 3c indicates that mRNA decay rates of RC3H1-
bound transcripts were decreased in cells depleted of RC3H1 and
RC3H2, suggesting that RC3H proteins destabilize their mRNA
targets.
In addition, we examined the effect of RC3H1 depletion on the
protein synthesis rate of RC3H1-bound mRNAs. For this
purpose, we monitored changes in newly synthesized proteins by
pulsed SILAC (pSILAC) based quantitative proteomics22,33 upon
depletion of endogenous RC3H1 in HEK293 cells (Supplementary
Fig.4a). The mass shift between the RC3H1 knockdown (‘medium’
labelled) and mock-treated control (‘heavy’ labelled) allowed the
quantification of changes in protein synthesis of B2,400 proteins
(Supplementary Fig. 4a). RC3H1 knockdown was confirmed by
western blot analysis (Supplementary Fig. 4b). A cumulative
distribution function analysis showed that the level of protein
synthesis of RC3H1-bound mRNAs was increased upon RC3H1
depletion by two short interfering RNA (siRNAs) (Fig. 3d and
Supplementary Fig. 4c,d). Taken together, our data indicate that
RC3H1-bound mRNAs are short lived, and depletion of RC3H1
resulted in decreased decay rates and increased proteins synthesis
of its target transcripts, validating the functionality of RC3H1–
mRNA interactions.
RC3H1 interacts with DNA damage-induced transcripts. Our
KEGG pathway enrichment analysis revealed that RC3H1 mRNA
targets are enriched for genes involved in cell cycle regulation and
p53 signalling (Supplementary Fig. 1e) Furthermore, RC3H1 was
shown to localize to stress granules upon oxidative stress induced
by arsenite exposure4, suggesting an involvement of RC3H1 in
the cellular stress response. To investigate a possible role of
RC3H1 in the DNA damage response, we correlated changes in
mRNA expression levels upon DNA damage induced by
neocarzinostatin in HEK293 cells34 with our RC3H1 PAR-CLIP
data (Fig. 4a). Notably, RC3H1-bound transcripts were more
induced upon DNA damage than unbound mRNAs (Fig. 4b).
This finding implies that the expression levels of DNA
damage-induced genes are likely modulated at the post-
transcriptional level at least in part by RC3H1. The mRNA of
A20, a NF-kB target gene that acts as a feedback regulator of
NF-kB activation, was among the RC3H1 target transcripts and
showed the largest increase in expression upon DNA damage.
Induction of FLAG/HA-tagged RC3H1 (Supplementary Fig. 5a)
in HEK293 cells resulted in a significant reduction of A20 mRNA
(Fig. 4c) upon DNA damage. Furthermore, we observed that A20
mRNA half-life was shortened by expression of tagged RC3H1
(Fig. 4d). To provide further support for this finding, we
specifically blocked the RC3H1-binding site on A20 mRNA by
transfecting an antisense locked nucleic acid (LNA)
oligonucleotide and observed an increase in A20 mRNA half-
life (Fig. 4e).
RC3H1 binding to A20 30UTR via ROQ and CCCH-Znf
domains. Our PAR-CLIP data indicated a single RC3H1-binding
site in the 30UTR of A20 mRNA. Diagnostic PAR-CLIP T to
C transition events, indicating protein–RNA crosslinking sites,
were detected in a loop of a conserved predicted hairpin and in an
AU-rich sequence located upstream of the stem–loop structure,
which differs from the previously described CDE (Fig. 5a).
To examine whether the putative A20-binding site bestows
RC3H1-dependent mRNA decay, we cloned a 37-bp sequence
covering the crosslinked region into a green fluorescent
protein (GFP) reporter and assayed mRNA turnover by
quantitative reverse transcription–PCR (qRT–PCR) after
blocking transcription using actinomycin D. Indeed, insertion of
the RC3H1-bound A20 site into the 30UTR of the reporter
construct destabilized reporter transcripts in mock-transfected
cells, but not in RC3H1- and RC3H2-depleted cells (Fig. 5b),
indicating that RC3H proteins destabilize the reporter transcripts
through this A20 site.
To further examine the RC3H1 interaction with the putative
A20 site, we used electrophoretic mobility shift assays (EMSA). In
addition, to assess the contribution of the different RC3H1
domains to RNA binding, we expressed two variants: RC3H1-N1
(aa 2–399) contained the N-terminal RING and ROQ domains,
whereas RC3H1-N2 (aa 2–452) harboured RING, ROQ and
CCCH-type Zn-finger domains (Fig. 5c). Both recombinant
proteins bound to the ICOS CDE-like stem–loop motif RNA
(Fig. 5c). The formation of the protein–RNA complex seemed to
be independent of the CCCH-type Zn-finger domain. In contrast,
the 21-nucleotide A20 hairpin RNA was bound by RC3H1-N2
with higher affinity than RC3H1-N1 (Fig. 5c), indicating that the
CCCH-type Zn-finger domain plays a role in the interaction with
the non-CDE-type A20 site. The addition of 16 nucleotides 50 of
the stem–loop structure (A20 37 nucleotide) further increased the
affinity of the RC3H1-N2 variant to the RNA substrate (Fig. 5c),
suggesting that an additional sequence upstream of the A20
hairpin is involved in protein–RNA complex formation. To
further study the specificity of RC3H1 interaction to its A20
stem–loop hairpin, we performed EMSA using stem–loop hairpin
or variants thereof (Fig. 5d). A single-nucleotide substitution in
the loop region virtually did not affect binding; however,
substitution of three nucleotides resulted in slight reduction of
binding (Fig. 5d). In contrast, a control sequence, which was
generated by concatenating three 7mers underrepresented in our
7mer analysis, did not bind to RC3H1, indicating a specificity for
the A20 hairpin (Fig. 5d). Moreover, the antisense LNA
oligonucleotide, which was used to modulate A20 mRNA stability
(Fig. 4e) and hybridizes to the loop and the 30part of the stem,
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reduced the binding of RC3H1-N2 to the 37-nucleotide A20
target sequence, suggesting that the specific blockade of both loop
and stem pronouncedly reduced RC3H1 binding to A20 30UTR
(Fig. 5e).
RC3H1 represses A20 and modulates the NF-jB pathway.
Notably, RC3H1-dependent mRNA regulation affects several
NF-kB pathway regulators5,9. A recent transcriptome-wide
RIP-seq study determining RC3H1-bound transcripts in mouse
macrophages revealed the cytokine TNFa—a typical activator of
NF-kB35,36—and two members of the IkB family, IkBNS
(NFKBID) and IkB-zeta (NFKBIZ)9. In addition to the
ubiquitin-editing enzyme A20, we identified IkBa in our
PAR-CLIP as an additional RC3H1 target transcript (Fig. 6a,b).
To examine whether RC3H1 acts in a pathway-specific
manner, we used previously published mRNA expression data
of TNFa-treated HEK 293 cells37 to correlate RC3H1-bound
mRNAs with TNFa-induced transcripts. Interestingly, RC3H1
target transcripts showed a greater increase in expression upon
TNFa induction than non-targets, suggesting that RC3H1 acts
post-transcriptionally on NF-kB target genes (Fig. 6a and
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Supplementary Fig. 5b). Furthermore, RC3H1 induction caused a
reduction of basal and stimulus-dependent A20 mRNA and
protein levels (Fig. 6b,c), similar to A20 expression changes
observed during the response after DNA damage (Fig. 4c).
Next, we asked whether RC3H1 could modulate NF-kB
activity. NF-kB activation is mediated via the IKK complex,
which catalyses the phosphorylation of IkB and NF-kB proteins,
as well as of other substrates35,36,38,39. Signalling involves
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ubiquitin-mediated complex formation of pathway components
and is controlled at various levels by negative feedback
mechanisms, including ubiquitin-editing enzymes such as A20
(ref. 40).
Indeed, RC3H1-mediated decrease of A20 protein levels led to
a significant increase of IKK activation (Fig. 6c), which was
repressed by additionally expressing exogenous A20 without
30UTR (Supplementary Fig. 5c). In line with this, elevated Ser536
phosphorylation of the IKK substrate p65 was observed (Fig. 6c).
However, IkBa degradation and NF-kB DNA-binding activity
were not detectably affected (Fig. 6c,d). To investigate the impact
of RC3H1 ectopic expression on the kinetics of the NF-kB
pathway and to understand the differential effect on IKK versus
NF-kB, a mathematical modelling approach was used, including
main processes of canonical IKK/NF-kB signalling
(Supplementary Fig. 5d). The model parameters were estimated
based on the western blot analysis for A20, IkBa and
phosphorylated IKK (Fig. 6c), as well as qPCR data for IkBa
and A20 mRNA levels (Fig. 6b; for details see Methods section).
The model simulations (Supplementary Fig. 5d) confirmed the
experimental findings that RC3H1 reduces A20 mRNA and
subsequently A20 protein expression, and, due to the attenuated
IKK inhibition by A20, leads to an increased IKK activity. In turn,
NF-kB activity is slightly increased by RC3H1, resulting in an
increased mRNA synthesis of the feedback regulators IkBa and
A20. According to the model, enhanced mRNA syntheses are
counteracted by the increased mRNA decay mediated by RC3H1
induction. For IkBa, this establishes a compensatory mechanism
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resulting in largely unaffected IkBa mRNA and protein levels
upon ectopic RC3H1 expression (Fig. 6b,c).
In contrast, knockdown of RC3H1 and RC3H2 in HEK293
cells resulted in a small, but reproducible, upregulation of A20
protein expression (Fig. 6e), which resulted in decreased
phosphorylation of IKK (Fig. 6e), decreased phosphorylation of
its substrate p65 (Fig. 6e) and reduced NF-kB DNA-binding
activity (Fig. 6f). These observations are also reproduced by the
mathematical model (Supplementary Fig. 5d) showing that a
strengthening of the A20 feedback leads to changes in activated
levels of IKK and NF-kB.
Taken together, we could demonstrate that RC3H1 regulates
the expression of several NF-kB pathway regulators, thereby
modulating IKK and NF-kB activity.
Discussion
In the present study, we identified transcriptome-wide RNA-
binding sites of human RC3H1 at nucleotide resolution in
HEK293 cells using PAR-CLIP. Our bioinformatic analyses did
not reveal a well-defined motif as observed for sets of RBPs41;
however, indicated several classes of sequence-structure binding
elements with U-rich sequences frequently embedded in RNA
stem–loop structures in 30UTRs of target transcripts. Surprisingly,
the CDE core consensus motif (UCYRYGA) deduced by
Leppek et al.9 was present only in a minor fraction of identified
RC3H1-binding sites. Our RC3H1 PAR-CLIP data are also in
agreement with the concept of a relaxed CDE revealed by
structural and mutational analyses10, which indicated a shape-
specific rather than sequence-specific recognition of CDE
hairpins by the ROQ domain.
Interestingly, our finding of a PAR-CLIP cluster in the A20
30UTR indicated a yet unrecognized RC3H1-binding mode and
specificity. In contrast to a typical CDE stem–loop motif, which is
sufficiently bound by the ROQ domain, we provide evidence that
the CCCH-type Zn-finger domain is involved in contacting the
A20 site. A RC3H1 variant containing the CCCH-type Zn-finger
domain bound with higher affinity to a non-CDE-like stem–loop
structure with an additional AU-rich sequence upstream of the
hairpin than to the hairpin alone. In contrast, the N-terminal
RC3H1 variant lacking the CCCH-type Zn-finger domain poorly
bound to both of these RNA substrates. The makeup of RC3H1
by distinct RNA-binding domains might allow the protein to
recognize a wider range of RNA structure-sequence elements
and could function on a larger set of regulatory elements
than previously anticipated. The ratio of sequence and
structure specificity features, determining the strength of the
RC3H1–mRNA association, and the RNA recognition element
frequency would influence the regulatory capacity of the RBP.
In addition, our results indicate that RC3H1 interacts with the
CCR4-CAF1-NOT deadenylation complex, and mediates desta-
bilization of RC3H1 target transcripts. RC3H1-bound mRNAs
are encoded by genes with various biological functions outside of
immune-response pathways, which is in accordance with the
mouse phenotype of Rc3h1 null-knockout that showed perinatal
lethality with broad physiological complications42. Enriched
KEGG pathways included cell cycle, p53 signalling and tumour
pathways. By intersecting our PAR-CLIP target mRNAs with
mRNA expression data, we found that RC3H1 targets are
enriched for mRNAs induced by DNA damage34 and TNFa37.
As shown for one of the top mRNA targets, A20, we postulate
that RC3H1, in general, is involved in fine-tuning or clearance of
transcriptionally induced mRNAs by shortening their half-lives.
Our discovery of RC3H1 binding to A20 mRNA and other
TNFa-induced transcripts prompted us to examine and model
the impact of RC3H1 on the IKK/NF-kB pathway. Knockdown of
RC3H1 and RC3H2 increased the expression of A20 protein
expression, resulting in reduced IKK activity and NF-kB DNA-
binding activity. Vice versa, we show that induction of RC3H1
results in pronounced increase of IKK phosphorylation. Taken
together, RC3H1 targets several components of the NF-kB
signalling pathway, and thereby modulates IKK and NF-kB
activity. The net impact of alterations in RC3H protein activity on
IKK and NF-kB activity in different cell types most likely depends
on various additional (cell-type) specific parameters. Notably,
IKK does not only regulate NF-kB activation but is also engaged
in crosstalk with other pathways40.
The Zn-finger protein A20 is an important negative regulator
of inflammation21, and several studies have highlighted the
clinical and biological importance of A20. Walle et al.43 recently
showed that negative regulation of the NLRP3 inflammasome by
A20 protects against arthritis. Since RC3H1 is a negative regulator
of A20, targeting of the RC3H1-A20 mRNA interaction by using
antisense technologies and concomitant upregulation of A20
protein might have beneficial outcomes in certain disease
scenarios.
In summary, we identified comprehensive RC3H1-binding
sites by PAR-CLIP, revealing a large number of novel mRNA
targets as well as novel RC3H1 cis-acting recognition element in
the A20 30UTR. Our study highlights the importance of post-
transcriptional regulation of gene expression to control crucial
cellular signal transduction pathways.
Methods
Antibodies. For western blots, the following antibodies were used after dilution to
0.5–1 mgml 1: anti-HA.11 (Covance, 16B12), anti-FLAG (Sigma, F1804), anti-
myc (Sigma, 9E10) anti-gH2AX(Upstate, JBW301), anti-vinculin (Sigma, hVIN-1),
anti-RC3H1 (Novus, NB100–655), anti-A20 (Santa Cruz Biotechnology, sc-32525),
anti-pIKK (Cell Signal Technology, 2,697), anti-IKKa (BD Pharmingen, 5,56,532),
anti-IkBa (Santa Cruz Biotechnology, sc-371), anti-p65 (Santa Cruz Biotechnology,
sc-8008P), anti-p-p65 (Cell Signaling Technology, 3033) and polyclonal goat anti-
mouse or anti-rabbit immunoglobulins/horseradish peroxidase (Dako).
Oligonucleotides
siRNAs. siRNA 1 for RC3H1: 50-GCUGGGAAAUACAAAGGAA[dT][dT].
siRNA 2 for RC3H1: 50-CCAAGAAAUGUGUAGAAGA[dT][dT].
RC3H2: 50-GGAAGAAGGUCGUGUAAGA[dT][dT].
qPCR primers. RC3H1 forward: 50-tggacaaccagaaccacaaa-30 ;
reverse: 50-GCTGATCCATTTGGTACATCAC-30 .
A20 forward: 50-TGCACACTGTGTTTCATCGAG-30;
reverse: 50-ACGCTGTGGGACTGACTTTC-30 .
RPL18A forward: 50-GGAGAGCACGCCATGAAG;
reverse: 50-AAGATTCGCATGCGGTAGAG-30.
GAPDH forward: 50-AGCCACATCGCTCAGACAC-30 ;
reverse: 50-GCCCAATACGACCAAATCC-30 .
NFKBIA forward: 50-GAGTCAGAGTTCACGGAGTTC-30 ;
reverse: 50-CATGTTCTTTCAGCCCCTTTG-30 .
d2GFP forward: 50-GAAGCTTAGCCATGGCTTCCC-30 ;
reverse: 50-GATGGCCGCATCTACACATTG-30 .
DNA oligos for d2GFP-A20 30UTR reporter. Sense: 50-GGCCTGTACAT
ATATAATATACCCTTACATTATGTATGAGGGATTTT-30 ;
antisense: 50-TCGAAAAATCCCTCATACATAATGTAAGGGTATATTATAT
ATGTACA-30.
RNA oligos. ICOS (13 nucleotide): 50-AUUUCUGUGAAAU-30 .
A20 (21 nucleotide): 50-CCCUUACAUUAUGUAUGAGGG-30 .
A20 (37 nucleotide): 50-AUAUAUAAUAUACCCUUACAUUA
UGUAUGAGGGAUUU-30.
Mut1 (21 nucleotide): 50-CCCUUACAUAAUGUAUGAGGG-30 .
Mut2 (21 nucleotide): 50-CCCUUACAAAAAGUAUGAGGG-30 .
Mut3 (21 nucleotide): 50-CCUCCCCCCCUGCCCCCCAGC-30 .
Plasmids. pENTR4 constructs were generated by PCR amplification of the
RC3H1 and QKI5 coding sequences from cDNA followed by restriction digest and
ligation into the pENTR4 (Invitrogen) backbone, which were further recombined
into the pFRT/TO/FLAG/HA-DEST destination vector44 using
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GATEWAY LR recombinase (Invitrogen) according to manufacturer’s protocol.
Expression plasmids for HA-tagged CNOT1 and CNOT8 were kind gifts from
Dr W. Filipowicz. pENTR4 QKI5 was recombined into pFRT/FLAG/HA-DEST
(Addgene ID: 26,360). The d2GFP reporter plasmids were generated by cloning the
d2GFP (Clontech) coding sequence into pcDNA5/FRT, and synthetic DNA
oligonucleotides containing the A20-binding site were annealed and ligated into
the 30UTR of d2GFP using the Xho1/Not1 site.
Cell lines and culture conditions. Flp-In 293 T-REx cells (Invitrogen) were grown
in Dulbecco’s modified Eagle’s medium high glucose with 10% (v/v) fetal bovine
serum, 2mM L-glutamine. Cell lines stably expressing FLAG/HA-tagged RC3H1
protein were generated by co-transfection of pFRT/TO/FLAG/HA constructs with
pOG44 (Invitrogen). Cells were selected by adding 15 mgml 1 blasticidin and
100mgml 1 hygromycin (Invivogen). Expression of epitope-tagged proteins was
induced by addition of 1 mgml 1 doxycyclin. The expression of FLAG/HA-tagged
RC3H1 protein was assessed by western analysis using mouse anti-HA.11 mono-
clonal antibody (Covance). For quantitative proteomics, cells were grown in SILAC
medium as described before30,45. Briefly, Dulbecco’s modified Eagle’s medium
GlutaMAX lacking arginine and lysine (PAA) supplemented with 10% dialysed
fetal bovine serum (Gibco) was used. Amino acids (84mg l 1 13C615N4 L-arginine
plus 146mg l 1 13C615N2 L-lysine or 84mg l-1 13C6-L-arginine plus 146mg l 1 D4-
L-lysine) or the corresponding non-labelled amino acids (Sigma) were added to
obtain ‘heavy’ ‘medium’ or ‘light’ cell culture medium, respectively. Labelled amino
acids were purchased from Sigma Isotec.
Western blot analysis. Total cell lysates were prepared in 1 SDS–PAGE sample
loading buffer (50mM Tris (pH 7.5), mercaptoethanol, 1% SDS, 0.01% bromo-
phenol blue and 10% glycerol) and resolved by SDS–PAGE. Proteins were trans-
ferred to nitrocellulose membrane (Whatman) using a semi-dry blotting apparatus
(Bio-Rad) at constant 20V for 1 h. The membrane was blocked in 5% non-fat milk
and incubated with primary antibody. Following incubation for 1 h at room
temperature, membranes were washed three times in TBST (150mM NaCl, 20mM
Tris-HCl (pH 7.5) and 0.1 % Tween) and incubated with horseradish peroxidase-
conjugated secondary antibody for 1 h. Following three additional TBST washes,
protein bands were visualized using ECL detection reagent (GE Healthcare) and a
LAS-4000 imaging system (GE Healthcare). Uncropped images of data shown in
the figures are provided in Supplementary Fig. 6.
PAR-CLIP. Stably transfected and inducible FLAG/HA-RC3H1 expressing cells
were labelled with 100 mM 4SU or 6SG for 8–9 h. After labelling the cells, PAR-
CLIP was performed essentially as described in ref. 19. Briefly, for 4SU-2 and one
6SG, ultraviolet-irradiated cells were lysed in NP40 lysis buffer (50mM HEPES-
KOH at pH 7.4, 150mM KCl, 2mM EDTA, 0.5% (v/v) NP40, 0.5mM dithiothreitol
(DTT) and complete EDTA-free protease inhibitor cocktail). After mild treatment
with RNase T1 (Fermentas) at final concentration of 1U ml 1 for 15min at room
temperature, immunoprecipitation was carried out with protein-G magnetic beads
(Invitrogen) coupled to anti-FLAG M2 antibody (Sigma) from extracts of FLAG/
HA-RC3H1 expressing and 4SU-labelled HEK 293 cells for 1 h at 4 C. For 4SU-1,
a high-salt lysis buffer (50mM Tris-HCl, 500mM NaCl, 1% (w/v) NP40, 1mM DTT
and complete EDTA-free protease inhibitor cocktail) was used for cell lysis
followed by sonication. After mild treatment with RNaseT1 at final concentration
of 1 unit per ml for 15min at room temperature, purification of the RC3H1/RNA
complex was performed with Flag magnetic beads (Sigma). Following additional
digestion by RNase T1 (Fermentas) at final concentration of 10 unit per ml for
2min at room temperature, beads were incubated with calf intestinal phosphatase
(NEB) and RNA fragments were radioactively end labelled using T4 polynucleotide
kinase (Fermentas). The crosslinked protein–RNA complexes were resolved on a
4–12% NuPAGE gel (Invitrogen). The SDS–PAGE gel was transferred to a nitro-
cellulose membrane (Whatman) and the protein–RNA complex migrating at an
expected molecular weight was excised. RNA was isolated by proteinase K (Roche)
treatment and phenol–chloroform extraction, ligated to 30 adapter. (50-AppTC
GTATGCCGTCTTCTGCTTG-InvdT-30 for 4SU-1, 50-AppTCTCGTATCGTAT
GCCGTCTTCTGCTTG-InvdT-30 for 4SU-2 and 50-AppTCTCTGCTCGTATGC
CGTCTTCTGCTTG-InvdT-30 for 6SG), and 50 adapter (50-rGrUrUrCrArGrArGr
UrUrCrUrArCrArGrUrCrCrGrArCrGrArUrC-30), reverse transcribed and PCR
amplified. The amplified cDNA was sequenced on a HighSeq2000 (Illumina) with a
1 51 nucleotide cycle for 4SU-2 and 6SG and on a Genome Analyzer II with a
1 36 cycle for 4SU-1.
PAR-CLIP data processing. The PAR-CLIP cDNA sequencing data were
processed by an automated PAR-CLIP analysis pipeline developed by
Lebedeva et al.22 with default settings. Briefly, the PAR-CLIP analysis pipeline
performs the following steps: (1) reads were mapped to the genome, and uniquely
aligned reads with up to one mismatch, insertion or deletion were used to build
binding clusters; (2) each binding cluster was assigned a score based on the number
of T to C or G to A mismatches and on the heterogeneity of distinct reads
contributing to the cluster. As the reads should originate from RC3H1-bound
transcripts, we regarded clusters aligning antisense to the annotated direction of
transcription as false positives. (3) Filtering was performed to obtain RC3H1 clusters
sites at an estimated 5% false-positive rate based on the assigned score for each
cluster. For each cluster, the position with the highest number of diagnostic
transition events was determined, and we defined this position as the preferred
crosslink site. To define the consensus clusters, we pooled reads from all three
experiments while ensuring that transition events are counted appropriately (T to C
only in reads originating from 4SU experiments and G to A only in reads from the
6SG experiment). Before the cutoff determination, clusters had to pass an additional
consensus filter, demanding that reads from at least two out of the three experiments
support the cluster. The resulting sets of clusters were denoted as the ‘consensus’ set.
Read alignment statistics, cluster length distribution, target gene identification,
cluster distribution, cluster coverage profiles, conservation profile and miRNA target
scan were generated by the PAR-CLIP analysis pipeline. The IGF2BP1 PAR-CLIP
data were obtained from GEO (GSE21578; ref. 19) and analysed using the same
PAR-CLIP analysis pipeline with similar settings. KEGG pathway and GO term
enrichment analysis was performed using the on-line DAVID programme46,47. The
top 1,000 transcripts (ranked by the number of PAR-CLIP diagnostic mutations
falling into 30UTR) were used for pathway enrichment analysis.
Motif analysis. 7mer occurrences were counted in 41 nucleotide windows around
the crosslink site identified in the 4SU and 6SG PAR-CLIP experiments using
custom Perl scripts. To examine the enrichment of each 7mer motif, 7mer fre-
quency occurring in RC3H1 consensus 30UTR-binding sites was compared with
that occurring in all 30UTR sequences retrieved from UTRdb48. The longest 30UTR
sequence for each gene was used in this analysis. To test whether RC3H1-binding
sites showed a preferred secondary structure, we used the library routines from the
Vienna RNA package 1.8.2 (ref. 49) to compute base pairing probabilities within 41
nucleotide sequences centred on the preferred crosslink positions of 30UTR-
binding sites. The resulting profiles were accumulated and averaged over all 30UTR
consensus binding sites or the negative control 41 nucleotide sequences randomly
selected from the 30UTRs of RC3H1 target transcripts. Stem–loop enrichment
analysis was done based on the output from RNAfold programme in the Vienna
RNA package. For the clustering of structured motifs, we started with the top 100
(ranked by number of diagnostic transition events divided by expression value)
RC3H1-binding sites (41 nucleotide length sequence centred around the preferred
crosslink site) determined by PAR-CLIP, and detected initial clusters by LocARNA
(version 1.7.16; refs 26,27) together with RNAclust (version 1.3; ref. 27) to produce
a hierarchical tree. RNAclust (which uses LocARNA) was run using default
parameters together with the RNAsoup option (./RNAclust.pl –fasta
top100_sequences.fasta –dir output_dir/ --RNAsoup). For each subcluster, we used
CMfinder (version 0.2; ref. 28) to search for a subset of sequences that has a
conserved sequence-structure motif. CMfinder generates both a sequence-structure
alignment (called seed alignment) as well as a covariance model, which we used to
search for further sequences in the top 1,000 binding sites for remote members of
this motif using cmsearch from the Infernal package (version 1.0.7; ref. 29). We
then cut the hierarchical tree at the point where we got structured motifs with the
largest coverage in the list of top 1,000 binding sites, which resulted in three
structured motifs. We kept two motifs (motifs 1 and 2) and discarded the third one,
since its seed alignment consisted of only five entries.
siRNA knockdown and pSILAC. Flp-In 293 T-REx cells were grown in SILAC
medium supplemented with ‘light’ labelled amino acids before siRNA knockdown
experiments. siRNAs were transfected at a final concentration of 50 nM using
Lipofectamine RNAiMAX (Invitrogen). Controls (mock) were treated with trans-
fection reagent only. Following 24 h of incubation, siRNA-transfected cells were
switched to ‘medium’ labelled SILAC medium, whereas mock control cells were
switched to ‘heavy’ labelled SILAC medium. After 24 h of labelling, cells were
harvested and equal amounts of siRNA- and mock-transfected cells were pooled,
lysed in urea buffer (8M urea and 100mM Tris-HCl, pH 8.3) and sonicated for 20 s
(two pulses, 60% power). Cell debris was removed by centrifugation (14,000g,
5min). Protein concentration was then measured by the Bradford colorimetric
assay. An amount of 100 mg of proteins were reduced in 2mM DTT for 30min at
25 C, and successively free cysteines were alkylated in 11mM iodoacetamide for
20min at room temperature in the dark. LysC digestion was performed by adding
LysC (Wako) in a ratio 1:40 (w/w) to the sample and incubating it for 18 h under
gentle shaking at 30 C. After LysC digestion, the samples were diluted three times
with 50mM ammonium bicarbonate solution, 7 ml of immobilized trypsin (Applied
Biosystems) were added and samples were incubated 4 h under rotation at 30 C.
Digestion was stopped by acidification with 10 ml of trifluoroacetic acid and trypsin
beads were removed by centrifugation. Fifteen micrograms of digest were desalted
on STAGE Tips, dried and reconstituted to 20 ml of 0.5 % acetic acid in water50.
A volume of 5 ml of each sample were injected in duplicate on a Liquid
chromatography-tandem mass spectrometry (LS-MS/MS) system (nanoLC-Ultra
1D (Eksigent) coupled to LTQ-Orbitrap Velos (Thermo)), using a 240-min
gradient ranging from 5 to 40% of solvent B (80% acetonitrile, 0.1 % formic acid;
solvent A¼ 5% acetonitrile and 0.1 % formic acid). For the chromatographic
separation,B25-cm-long capillary (75 mm inner diameter) was packed with 1.8 mm
C18 beads (Reprosil-AQ, Dr Maisch). The capillary nanospray tip was generated
using a laser puller (P-2000 Laser Based Micropipette Puller, Sutter Instruments),
allowing fritless packing. The nanospray source was operated with spay voltage of
2.1 kV and ion transfer tube temperature of 260 C. Data were acquired in data-
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dependent mode, with one survey mass spectrometry (MS) scan in the Orbitrap
mass analyser (resolution 60,000 at m/z 400) followed by up to 20MS/MS in the
ion trap on the most intense ions (intensity threshold¼ 750 counts). Once selected
for fragmentation, ions were excluded from further selection for 30 s in order to
increase new sequencing events. Raw data were analysed using the MaxQuant
proteomics pipeline (v1.3.0.5) and the built-in Andromeda search engine51
with the International Protein Index Human version 3.71 database.
Carbamidomethylation of cysteines was chosen as fixed modification, and
oxidation of methionine and acetylation of N terminus were chosen as variable
modifications. The search engine peptide assignments were filtered at 1% False
Discovery Rate (FDR) and the feature match between runs was enabled; other
parameters were left as default. For SILAC analysis, two ratio counts were set as
threshold for quantification
RC3H1 protein interactome. For the identification of proteins directly interacting
with RC3H1, cells are grown in medium supplemented with either light or heavy
stable isotope-labelled amino acids. In the forward experiments, FLAG/HA-tagged
RC3H1 was expressed only in cells cultured in light medium, and in the reverse
experiments the labelling was swapped. Equal amounts of cells were mixed and lysed
in three pellet volumes of NP40 lysis buffer (50mM Tris-HCl (pH 7.5), 150mM KCl,
2mM EDTA (pH 8.0), 0.5% NP40, 1mM NaF, 0.5mM DTT and protease inhibitor
cocktail). The extracts were treated with 1 unit per ml RNase T1 for 5min at 22 C to
facilitate the immunoprecipitation and incubated with FLAG magnetic beads (Sigma;
50ml 1 1ml cell lysate) for 1 h at 4 C. Beads were washed once with NP40 lysis
buffer and treated with 50 unit per ml RNase T1 and 0.25 unit per ml RNase I for
5min at 37 C to disrupt RNA-mediated protein interactions. After washing the
beads once with FLAG elution buffer (100mM NaCl, 20mM Tris-HCl (pH 7.5), 5mM
MgCl2 and 10% glycerol), FLAG/HA-RC3H1 complex was eluted by adding
0.5mgml 1 FLAG peptide and rotating for 1 h at 4 C. mMACS HA magnetic beads
(50ml perml cell lysate) was added to FLAG eluate and incubated on ice for 30min.
FLAG eluate anti-HA bead mix was added to the mMACS column after equilibrating
with FLAG elution buffer. After washing the column three times with 800ml ice-cold
wash buffer I (150mM NaCl, 50mM Tris-HCl (pH 7.5), 5% glycerol and 0.05%
NP40) and twice with 500ml ice-cold wash buffer II (50mM NaCl, 50mM Tris-HCl
(pH 7.5) and 5% glycerol), a tryptic digestion was performed on-column by
adding 25ml 2 M urea in 100mM Tris-HCl (pH 7.5), 1mM DTT and 150 ng trypsin
(Promega). After in-column digestion for 30min at room temperature, peptides were
eluted by adding two times 50ml 2M urea in 100mM Tris-HCl (pH 7.5) and 5mM
iodoacetamide. Proteins were further digested overnight at room temperature being
protected from light, and digestion was stopped by adding 1ml trifluoroacetic acid.
Resulting peptides were analysed by mass spectrometry.
Quantitative PCR. Cells were harvested and total RNA was isolated using Trizol
(Invitrogen) according to manufacturer’s protocol. Total RNA was treated with
DNaseI (Invitrogen), and cDNA synthesis was performed using Superscript III
(Invitrogen) with oligo-dT primer (18–20 nucleotides) or random hexamer primer
(Invitrogen) according to manufacturer’s protocol. qPCR analysis was performed
with Power SYBR Green PCR Master Mix (ABI) and ABI light cycler as described
in the manufacturer’s instructions.
mRNA decay measurement by qRT–PCR. Cells were treated with 5 mgml 1 of
actinomycin D (Sigma-Aldrich) to block the transcription. At 0, 2 and 4 h post-
actinomycin D treatment, total RNA was harvested using Trizol (Invitrogen)
according to manufacturer’s protocol. Abundance of specific RNA was quantified
by qRT–PCR. mRNA levels were normalized against RPL18A mRNA and plotted
against time.
LNA transfection. LNA oligonucleotide (Exiqon) antisense to the RC3H1-bound
stem–loop located in the 30UTR of A20 (þAAþATþCCþCTþCAþTAþ
CAþTAAþT) was transfected at a final concentration of 100 nM using Lipo-
fectamine RNAiMAX (Invitrogen). For control experiment, control LNA (Exiqon)
targeting a region in the 30UTR of A20 (þTCCAþCCTCþCCCTþCCCþ
CCþA) not bound by RC3H1 was transfected as above. Note that þ indicates
that the following position is a LNA-modified residue. For mRNA decay assay after
antisense inhibition at 4 h after the transfection of LNA, medium was replaced with
fresh medium containing 250 ngml 1 of neocarzinostatin (Sigma-Aldrich) to
induce DNA damage and A20 expression. 5 h after induction of DNA damage,
mRNA decay assay was performed. Random hexamer primers (Invitrogen) were
used for cDNA generation.
mRNA half-life and decay measurements. To calculate the changes of mRNA
decay rates upon depletion of RC3H1 and RC3H2, cells were transfected with
RC3H1/RC3H2 siRNAs at days 0 and 3. At day 6, untreated and siRNA-treated
cells were supplemented with actinomycin D (50 mgml 1) to block transcription,
and harvested at time 0, 1 and 2 h after actinomycin D treatment. Experiments are
done in biological replicates for each time point. Total RNA was extracted using
Trizol, supplemented with 5% Drosophila melanogaster total RNA and subjected to
high-throughput sequencing using the TruSeq RNA sample prep v2 kit (Illumina).
The 12 samples were sequenced on a Illumina HiSeq 2,500 and mapped to the
human genome version hg18 using tophat2 (ref. 52). Non-redundant reads per
gene were counted using quasR53. For decay determination, read counts were
divided by the sum of the reads matching to the Drosophila transcriptome and by
transcript length, and log2-transformed. Decay rates were estimated using linear
least-squares regression on the data of two biological replicates. We used quantile
normalization of the two sets of decay rates to remove potential biases from
normalization. Differences in decay rates were computed by subtracting decay rates
of siRNA-treated samples from the decay rates of the mock-treated samples.
4SU-based measurement of mRNA half-lives was performed as described in ref. 32.
Briefly, HEK293 cells were treated with 100 mM 4SU for 60min. Total cellular RNA
was isolated using Trizol reagent. Biotinylation of 4SU-labelled RNA was
performed using EZ-Link Biotin-HPDP (N-[6-(biotinamido)hexyl]-30-(20-
pyridyldithio)propionamide) (Pierce) dissolved in dimethylformamide.
Biotinylation was carried out in 10mM Tris (pH 7.4), 1mM EDTA and
0.2mgml 1 biotin-HPDP at a final RNA concentration of 100 ng ml 1 for 1.5 h at
room temperature. An amount of 50–100 mg of total RNA was used for the
biotinylation reaction. Unbound Biotin-HPDP was efficiently removed by
chloroform:isoamyl alcohol (24:1) extraction using Phase-lock-gel (heavy) tubes
(Eppendorf). Then, a 1/10 volume of 5M NaCl and an equal volume of
isopropanol were added, and RNA was precipitated at 20,000g for 20min. The
pellet was washed with an equal volume of 75% ethanol and precipitated at 20,000g
for 10min. The pellet was resuspended in 50–100 ml RNase-free water. After
denaturation of RNA samples at 65 C for 10min followed by rapid cooling on ice
for 5min, biotinylated RNA was captured using mMACS streptavidin beads and
columns (Miltenyi). Up to 100mg of biotinylated RNA were incubated with 100ml
of mMACS streptavidin beads with rotation for 15min at room temperature. The
beads were transferred and magnetically fixed to the columns. Columns were
washed three times with 1ml 65 C washing buffer (100mM Tris-HCl (pH 7.4)
10mM EDTA, 1M NaCl and 0.1% Tween20) followed by three washes with room
temperature washing buffer. To recover the unlabelled pre-existing RNA the flow-
through of the first two washes was collected and combined. Labelled RNA was
eluted by adding 100 ml of freshly prepared 100mM DTT followed by a second
elution 5min later. RNA was recovered from the washing fractions and eluates
using the RNeasy MinElute Spin columns (Qiagen). Total RNA (1.5 mg) and newly
transcribed RNA (280 ng) were amplified and labelled using the Affymetrix One-
Cycle Target Labeling Kit according to the manufacturer’s protocol. As newly
transcribed RNA mainly consists of mRNA, it was amplified and labelled according
to the manufacturer’s protocol for mRNA. The amplified and fragmented
biotinylated cRNA was hybridized to Affymetrix Human Gene 1.0 ST Arrays using
standard procedures. Data were processed and analysed with R and Bioconductor.
To calculate RNA half-lives, CEL-files of all samples from all conditions (including
total RNA, newly transcribed RNA and pre-existing RNA) were normalized
together using the GCRMA algorithm. Only probe sets called ‘present’ in all three
replicates of all three RNA subsets under study were included in the analysis of
transcript half-lives. Calculation of RNA half-lives was done as performed 32.
Statistical comparison of half-life values between groups was performed using the
Wilcoxon rank-sum test.
Recombinant protein expression and purification. DNA encoding the RING
and ROQ domains (RC3H1-N1; aa 2–399) or the RING, ROQ and CCCH-Znf
domains (RC3H1-N2; aa 2–452) was subcloned into the pQLinkH vector54. The
genes were expressed as N-terminal His7-tagged proteins at 17 C in Escherichia
coli Rosetta 2 (DE3, (Novagen) using a LEX ultra-high-throughput bench-top
bioreactor (Harbinger Biotech). Cells were grown at 37 C in Terrific Broth
medium and induced at an OD600 of 2.0–2.5 with 0.5mM isopropyl b-D-1-
thiogalactopyranoside. For purification, cells were resuspended in phosphate-
buffered saline lysis buffer (1 phosphate-buffered saline, pH 7.4, 0.5M NaCl, 5%
(v/v) glycerol and 0.5mM DTT), supplemented with 0.25% (w/v) 3-[(3-cholami
dopropyl) dimethylammonio]-1-propanesulfonate, 0.1mM phenylmethyl sulfonyl
fluoride, 1Uml 1 RNase-free DNase I (Qiagen) and one tablet of EDTA-free
Complete Protease Inhibitor (Roche). The purification procedure comprises
mechanical cell lysis by sonication (SONOPULS HD 2200, Bandelin), an Ni/Zn
affinity chromatography on a 5-ml HisTrap FF crude column (GE Healthcare), and
a size-exclusion chromatography on a Superdex 200 prep grade column (XK
26 60, GE Healthcare). The His7 tag was cleaved with tobacco etch virus protease
before the gel filtration step, followed by a reapplication of the cleaved protein on
the Ni/Zn affinity column. The purification of protein constructs comprising the
RING, ROQ and CCCH-Znf domains additionally included a cation-exchange
chromatography on a Source 30S column (HR 16 10, GE Healthcare).
Electrophoretic mobility shift assay. The EMSA was performed according to
Ryder et al.55 with the following modifications: RNA was prepared by 50-end
labelling of commercially synthesized RNA oligonucleotides with [g-32P]-ATP
using T4 polynucleotide kinase (NEB). Labelled RNA was gel-purified, eluted and
adjusted with H2O to 1 pmolml 1. Labelled RNA (50 fmol) was used per 20 ml
reaction. Before binding reactions, a master mix containing labelled RNA, 1
binding buffer (20mM Tris-HCl (pH 7.5), 50mM KCl, 5mM MgCl2, 20 mM ZnSO4
and 10% glycerol), 2mM DTT, 0.05mgml 1 BSA and 5 mgml 1 heparin was
heated at 90 C for 1min and gradually cooled down to room temperature. In
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parallel, a dilution series of 10 protein stocks was prepared in 1 protein
dilution buffer (1 binding buffer and 5 mgml 1 heparin). For each binding
reaction, 2 ml of the 10 protein stock was added to 18 ml of the mastermix at
room temperature for 2 h. After addition of 4 ml 6 loading buffer (30% glycerol,
bromophenol blue and xylene cyanol), RNA-protein complexes were resolved by
nondenaturing PAGE (6% polyacrylamide, 0.5 Tris-borate-EDTA (TBE) and 5%
glycerol) in ice-cold 0.5 TBE buffer containing 20mM ZnSO4 at 100V for
40min. The protein-bound RNA and the free RNA were quantified using a
phosphorimager.
To determine NF-kB DNA-binding activity, EMSA was performed according to
Hinz et al.56 using the following protocol. An amount of 4–10 mg of whole-cell
lysate was mixed with radioactive-labelled (25,000 c.p.m.) oligonucleotides
containing a NF-kB site (50-gatcCAGGGCTGGGGATTCCCCATCTCCACAGG-
30 and 50-gatcCCTGTGGAGATGGGGAATCCCCAGCCCTG-30), 2 mg poly(dI-
dC), 1 mg BSA and 1mM DTT in 20ml reaction buffer (20mM HEPES (pH 8.4),
60mM KCI and 8% Ficoll) Samples were incubated for 30min at 25 C and
analysed by native PAGE (5 % gels; TBE buffer), followed by autoradiography.
Microarray data processing. Microarray raw data for DNA damage response and
TNFa response were retrieved from GEO accessions GSE1676 and GSE28548,
respectively. Robust multi-array average background correction and quantile
normalization was applied using affyR Bioconductor packages57. For the analysis of
Affymetrix Human Genome U133 Plus 2.0 Array, probe set intensities mapping to
the same gene were averaged to summarize into gene intensities, and genes with
log2 steady-state expression level o5 were filtered out.
Mathematical modelling of NF-jB pathway. The computational model of the
canonical IKK/NF-kB system is described by an ordinary differential equation
system:
A200 ¼ k9A20mRNA  k3A20
A200mRNA ¼ k12NFkB k7A20mRNARC3H1A20
IKK0act ¼ TNFak10eA20 þ k2=ðk2 þA20Þ k4IKKact
NF-kB j IkBa0 ¼ k1IkBaNFkB k14NF-kB j IkBa k6IKKactNF-kB j IkBa
IkBa0 ¼ k14NF-kB j IkBa k1IkBaNFkBþ k11IkBamRNA  k5IkBa
IkBa0mRNA ¼ k13NFkB k8IkBamRNARC3H1IkBa
NFkB0 ¼ k6IKKactNF-kB j IkBa k1IkBaNFkBþ k14NF-kB j IkBa
The western blot data of three replicates for phosphorylated IkBa and IKK
upon TNFa stimulation with and without RC3H1 induction were quantified using
ImageJ. The mRNA levels of IkBa and A20 upon TNFa stimulation with and
without RC3H1 induction were measured with qPCR. The parameters of the model
were estimated with the Data2Dynamics software package in MATLAB (R2013b,
The Mathworks Inc., Natick, MA) using the build-in function lsqnonlin and latin
hypercube parameter sampling58. One representative parameter set is given in
Supplementary Table 3.
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